Benitec Biopharma Inc (BNTC)

Etorro trading 970x250
Benitec Biopharma Inc (BNTC) Logo

About Benitec Biopharma Inc

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California. Address: 3940 Trust Way, Hayward, CA, United States, 94545

Benitec Biopharma Inc News and around…

Latest news about Benitec Biopharma Inc (BNTC) common stock and company :

Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results
20 Sep, 2021 Yahoo! Finance

Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today provided an operational update and announced the financial results for its fiscal year ended June 30, 2021. The Company has filed its annual report on Form 10-K for the year ended June 30, 2021, with the U.S. Securities and Exchange Commission.

Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
13 Sep, 2021 Yahoo! Finance

Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec Biopharma will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The relevant details are outlined below:

Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
08 Sep, 2021 Yahoo! Finance

Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an overview of the key elements of the BB-301 Phase 1b/2a clinical trial design. The clinical trial is planned for 2022.

Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
08 Sep, 2021 Yahoo! Finance

Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an update on the ongoing analyses of the large animal subjects treated with BB-301 in the Pilot Dosing Study. Interim data from the BB-301 Pilot Dosing Study were disclosed in February 2021 via press release and presentation and subsequently discussed with European regulators in the first half of 2021. The updated BB-301 analyses outlined today co

Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
08 Sep, 2021 Yahoo! Finance

Regulatory Update Highlights:

Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth?
31 May, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

77 Biggest Movers From Yesterday
14 May, 2021 FinancialContent

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped ...

44 Stocks Moving In Thursday's Mid-Day Session
13 May, 2021 FinancialContent

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
13 May, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting the day off right with a look at the biggest pre-market stock movers for Thursday with earnings backing much of that movement. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

26 Stocks Moving in Thursday's Pre-Market Session
13 May, 2021 FinancialContent

Gainers Fuel Tech, Inc. (NASDAQ: FTEK) shares rose 26.3% to $2.45 in pre-market trading after the company reported upbeat results ...

60 Biggest Movers From Yesterday
29 Apr, 2021 FinancialContent

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently ...

Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged
28 Apr, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the ...

Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge
28 Apr, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also ...

41 Stocks Moving In Wednesday's Mid-Day Session
28 Apr, 2021 FinancialContent

Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an ...

Why Is It Moving? Looking Into Why Benitec Biopharma's Stock is Trading Lower Today
28 Apr, 2021 FinancialContent

The Price And Volume Action In Benitec Biopharma's Stock Today Benitec Biopharma (NASDAQ:BNTC) is currently down 24.48% to a ...

Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations
28 Apr, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P ...

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
28 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
28 Apr, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors need to get ready for another busy day of trading with our top pre-market stock movers list of winners and losers on Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

25 Stocks Moving in Wednesday's Pre-Market Session
28 Apr, 2021 FinancialContent

Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The ...

Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million
28 Apr, 2021 Yahoo! Finance

Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 3,036,366 shares of common stock of the Company at a price to the public of $4.25 per share, less underwriting discounts and commissions. The Company has also granted the underwriter a 30-day option to purchase up to an additional 455,454 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 30, 2021, subject to satisfaction of customary closing conditions.

Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock
27 Apr, 2021 Yahoo! Finance

Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 1,764,705 shares of common stock of the Company at a price to the public of $4.25 per share, less underwriting discounts and commissions. The Company has also granted the underwriter a 30-day option to purchase up to an additional 264,705 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 30, 2021, subject to satisfaction of customary closing conditions.

54 Biggest Movers From Yesterday
06 Apr, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares climbed 60.2% to close at $5.64 on Monday after the company announced the ...

35 Stocks Moving In Monday's Mid-Day Session
05 Apr, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) jumped 46% to $5.14 after the company announced the commercial launch of a test ...

71 Biggest Movers From Yesterday
01 Apr, 2021 FinancialContent

Gainers Discovery, Inc. (NASDAQ: DISCB) shares gained 82.8% to close at $128.00 after climbing around 29% on Tuesday. Wah Fu ...

50 Biggest Movers From Yesterday
30 Mar, 2021 FinancialContent

Gainers ThredUp Inc. (NASDAQ: TDUP) shares jumped 57% to close at $31.40 on Monday. The company, on Friday, priced its ...

42 Stocks Moving In Thursday's Mid-Day Session
25 Mar, 2021 FinancialContent

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) climbed 64.2% to $5.73. Cellect Biotechnology and Quoin Pharmaceuticals reported ...

30 Stocks Moving in Thursday's Pre-Market Session
25 Mar, 2021 FinancialContent

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 73% to $6.03 in pre-market trading. Cellect Biotechnology and Quoin ...

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning
25 Mar, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market movers this morning include some high-profile top gainers and losers. Take a look at this list that includes NFT stocks and EV plays. The post Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now

64 Biggest Movers From Yesterday
25 Mar, 2021 FinancialContent

Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on Wednesday. WISeKey International ...

Best Stocks To Invest In Right Now? 4 Biotech Stocks To Know
24 Mar, 2021 FinancialContent

Benitec Biopharma Inc (BNTC) is a NASDAQ Common Stock listed in , ,

970x250